BNAb and Peptide Targeting HIV

Targets of broadly neutralizing antibodies (BNAbs) might be exploited for HIV-1 vaccine design and antibody-mediated therapy. Therapeutic peptides are alternative strategies for HIV-1 treatment as there are several advantages of using macromolecules as inhibitors. https://www.creative-biolabs.com/antinfect/discovery-of-broadly-neutralizing-antibody-bnab-and-peptide-targeting-hiv.htm Read less